[Confusion and chorea triggered by the association of ipratropium bromide and salbutamol administered by inhaler].
Rodríguez-Uranga
J J
JJ
Servicio de Neurología, Hospitales Universitarios Virgen del Rocio, Sevilla, España.
Franco-Macías
E
E
Sanz-Fernández
G
G
Gil-Néciga
E
E
D000280:Administration, Inhalation; D000368:Aged; D000369:Aged, 80 and over; D000420:Albuterol / Q000008:administration & dosage / Q000009:adverse effects*; D018678:Cholinergic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002819:Chorea / Q000139:chemically induced*; D003221:Confusion / Q000139:chemically induced*; D005260:Female; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage / Q000009:adverse effects*; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*
D018678:Cholinergic Agents; D009241:Ipratropium; D000420:Albuterol
Confusion y corea desencadenados por la asociación de bromuro de ipratropio y salbutamol inhalados.